Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial
To assess visual function more than 10 years after an episode of optic neuritis in patients enrolled in the Optic Neuritis Treatment Trial. Longitudinal follow-up of a randomized clinical trial. Vision testing included measures of visual acuity, contrast sensitivity, and visual field. Quality of lif...
Gespeichert in:
| Veröffentlicht in: | American journal of ophthalmology 2004, Vol.137 (1), p.77-83 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 83 |
|---|---|
| container_issue | 1 |
| container_start_page | 77 |
| container_title | American journal of ophthalmology |
| container_volume | 137 |
| creator | Beck, Roy W Gal, Robin L Bhatti, M Tariq Brodsky, Michael C Buckley, Edward G Chrousos, Georgia A Corbett, James Eggenberger, Eric Goodwin, James A Katz, Barrett Kaufman, David I Keltner, John L Kupersmith, Mark J Miller, Neil R Moke, Pamela S Nazarian, Sarkis Orengo-Nania, Silvia Savino, Peter J Shults, William T Smith, Craig H Trobe, Jonathan D Wall, Michael Xing, Dongyuan |
| description | To assess visual function more than 10 years after an episode of optic neuritis in patients enrolled in the Optic Neuritis Treatment Trial.
Longitudinal follow-up of a randomized clinical trial.
Vision testing included measures of visual acuity, contrast sensitivity, and visual field. Quality of life was assessed with the National Eye Institute Visual Function Questionnaire.
Examinations were completed on 319 patients. In most patients, visual function test results in the eyes that experienced optic neuritis at study entry (“affected eyes”) were normal or only slightly abnormal after 9.9 to 13.7 years. Visual acuity in the affected eyes was ≥20/20 in 74%, 20/25 to 20/40 in 18%, |
| doi_str_mv | 10.1016/S0002-9394(03)00862-6 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80079071</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002939403008626</els_id><sourcerecordid>3556245451</sourcerecordid><originalsourceid>FETCH-LOGICAL-c452t-4018aba7e0b64a31482d2c74a59aeaa293d51b2ecfcb788821539cf512c1dfa03</originalsourceid><addsrcrecordid>eNqFkV1rFjEQhYNY7Gv1JygBUfRiNclmN4k3IkVtoeCFH7dhNjvBlN3sa5KV9t-b9wMLvfFimBl4zjCcQ8gzzt5yxvt33xhjojGtka9Z-4Yx3Yumf0A2XCvTcG34Q7L5h5ySxzlf17VXUj0ip1yqOku1IeFnyCtM1K_RlbBEOi8JafkFkXJGbxFSpuALJrpsS3A04ppCCfk9xZstpoDRIV18VeA9gpaEUGaMpU4BpifkxMOU8emxn5Efnz99P79orr5-uTz_eNU42YnSSMY1DKCQDb2ElkstRuGUhM4AAgjTjh0fBDrvBqW1FrxrjfMdF46PHlh7Rl4d7m7T8nvFXOwcssNpgojLmq1mTBmmeAVf3AOvlzXF-pvlvZS6ljSV6g6US0vOCb3dpjBDurWc2V0Sdp-E3dlsWWv3Sdi-6p4fr6_DjOOd6mh9BV4eAcgOJp8gupDvuE5L0_U77sOBw2ran4DJZre3fQwJXbHjEv7zyl-TcaVo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1644864449</pqid></control><display><type>article</type><title>Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Beck, Roy W ; Gal, Robin L ; Bhatti, M Tariq ; Brodsky, Michael C ; Buckley, Edward G ; Chrousos, Georgia A ; Corbett, James ; Eggenberger, Eric ; Goodwin, James A ; Katz, Barrett ; Kaufman, David I ; Keltner, John L ; Kupersmith, Mark J ; Miller, Neil R ; Moke, Pamela S ; Nazarian, Sarkis ; Orengo-Nania, Silvia ; Savino, Peter J ; Shults, William T ; Smith, Craig H ; Trobe, Jonathan D ; Wall, Michael ; Xing, Dongyuan</creator><creatorcontrib>Beck, Roy W ; Gal, Robin L ; Bhatti, M Tariq ; Brodsky, Michael C ; Buckley, Edward G ; Chrousos, Georgia A ; Corbett, James ; Eggenberger, Eric ; Goodwin, James A ; Katz, Barrett ; Kaufman, David I ; Keltner, John L ; Kupersmith, Mark J ; Miller, Neil R ; Moke, Pamela S ; Nazarian, Sarkis ; Orengo-Nania, Silvia ; Savino, Peter J ; Shults, William T ; Smith, Craig H ; Trobe, Jonathan D ; Wall, Michael ; Xing, Dongyuan ; THE OPTIC NEURITIS STUDY GROUP ; Optic Neuritis Study Group</creatorcontrib><description>To assess visual function more than 10 years after an episode of optic neuritis in patients enrolled in the Optic Neuritis Treatment Trial.
Longitudinal follow-up of a randomized clinical trial.
Vision testing included measures of visual acuity, contrast sensitivity, and visual field. Quality of life was assessed with the National Eye Institute Visual Function Questionnaire.
Examinations were completed on 319 patients. In most patients, visual function test results in the eyes that experienced optic neuritis at study entry (“affected eyes”) were normal or only slightly abnormal after 9.9 to 13.7 years. Visual acuity in the affected eyes was ≥20/20 in 74%, 20/25 to 20/40 in 18%, <20/40 to 20/200 in 5%, and <20/200 in 3%. On average, visual function was worse in patients with multiple sclerosis (MS) than in those without MS. Recurrent optic neuritis in either eye occurred in 35% of patients. Such attacks were more frequent in patients with MS (
P < .001). The National Eye Institute Visual Function Questionnaire scores were lower when visual acuity was abnormal and when MS was present.
Most patients retained good to excellent vision more than 10 years after an attack of optic neuritis. Recurrences were more frequent in patients with MS.</description><identifier>ISSN: 0002-9394</identifier><identifier>EISSN: 1879-1891</identifier><identifier>DOI: 10.1016/S0002-9394(03)00862-6</identifier><identifier>PMID: 14700647</identifier><identifier>CODEN: AJOPAA</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Biological and medical sciences ; Contrast Sensitivity - physiology ; Diabetic retinopathy ; Diseases of visual field, optic nerve, optic chiasma and optic tracts ; Female ; Follow-Up Studies ; Glucocorticoids - therapeutic use ; Health Status Indicators ; Humans ; Independent sample ; Male ; Medical sciences ; Middle Aged ; Multiple sclerosis ; Multiple Sclerosis - physiopathology ; National Institutes of Health (U.S.) - standards ; NMR ; Nuclear magnetic resonance ; Ophthalmology ; Optic Neuritis - drug therapy ; Optic Neuritis - physiopathology ; Patients ; Quality of Life ; Questionnaires ; Recurrence ; Surveys and Questionnaires ; United States ; Vision Tests ; Visual Acuity - physiology ; Visual Fields - physiology</subject><ispartof>American journal of ophthalmology, 2004, Vol.137 (1), p.77-83</ispartof><rights>2004 Elsevier Inc.</rights><rights>2004 INIST-CNRS</rights><rights>Copyright Elsevier Limited Jan 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c452t-4018aba7e0b64a31482d2c74a59aeaa293d51b2ecfcb788821539cf512c1dfa03</citedby><cites>FETCH-LOGICAL-c452t-4018aba7e0b64a31482d2c74a59aeaa293d51b2ecfcb788821539cf512c1dfa03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0002-9394(03)00862-6$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,4025,27928,27929,27930,46000</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15849567$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14700647$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Beck, Roy W</creatorcontrib><creatorcontrib>Gal, Robin L</creatorcontrib><creatorcontrib>Bhatti, M Tariq</creatorcontrib><creatorcontrib>Brodsky, Michael C</creatorcontrib><creatorcontrib>Buckley, Edward G</creatorcontrib><creatorcontrib>Chrousos, Georgia A</creatorcontrib><creatorcontrib>Corbett, James</creatorcontrib><creatorcontrib>Eggenberger, Eric</creatorcontrib><creatorcontrib>Goodwin, James A</creatorcontrib><creatorcontrib>Katz, Barrett</creatorcontrib><creatorcontrib>Kaufman, David I</creatorcontrib><creatorcontrib>Keltner, John L</creatorcontrib><creatorcontrib>Kupersmith, Mark J</creatorcontrib><creatorcontrib>Miller, Neil R</creatorcontrib><creatorcontrib>Moke, Pamela S</creatorcontrib><creatorcontrib>Nazarian, Sarkis</creatorcontrib><creatorcontrib>Orengo-Nania, Silvia</creatorcontrib><creatorcontrib>Savino, Peter J</creatorcontrib><creatorcontrib>Shults, William T</creatorcontrib><creatorcontrib>Smith, Craig H</creatorcontrib><creatorcontrib>Trobe, Jonathan D</creatorcontrib><creatorcontrib>Wall, Michael</creatorcontrib><creatorcontrib>Xing, Dongyuan</creatorcontrib><creatorcontrib>THE OPTIC NEURITIS STUDY GROUP</creatorcontrib><creatorcontrib>Optic Neuritis Study Group</creatorcontrib><title>Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial</title><title>American journal of ophthalmology</title><addtitle>Am J Ophthalmol</addtitle><description>To assess visual function more than 10 years after an episode of optic neuritis in patients enrolled in the Optic Neuritis Treatment Trial.
Longitudinal follow-up of a randomized clinical trial.
Vision testing included measures of visual acuity, contrast sensitivity, and visual field. Quality of life was assessed with the National Eye Institute Visual Function Questionnaire.
Examinations were completed on 319 patients. In most patients, visual function test results in the eyes that experienced optic neuritis at study entry (“affected eyes”) were normal or only slightly abnormal after 9.9 to 13.7 years. Visual acuity in the affected eyes was ≥20/20 in 74%, 20/25 to 20/40 in 18%, <20/40 to 20/200 in 5%, and <20/200 in 3%. On average, visual function was worse in patients with multiple sclerosis (MS) than in those without MS. Recurrent optic neuritis in either eye occurred in 35% of patients. Such attacks were more frequent in patients with MS (
P < .001). The National Eye Institute Visual Function Questionnaire scores were lower when visual acuity was abnormal and when MS was present.
Most patients retained good to excellent vision more than 10 years after an attack of optic neuritis. Recurrences were more frequent in patients with MS.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Contrast Sensitivity - physiology</subject><subject>Diabetic retinopathy</subject><subject>Diseases of visual field, optic nerve, optic chiasma and optic tracts</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Glucocorticoids - therapeutic use</subject><subject>Health Status Indicators</subject><subject>Humans</subject><subject>Independent sample</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Multiple sclerosis</subject><subject>Multiple Sclerosis - physiopathology</subject><subject>National Institutes of Health (U.S.) - standards</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Ophthalmology</subject><subject>Optic Neuritis - drug therapy</subject><subject>Optic Neuritis - physiopathology</subject><subject>Patients</subject><subject>Quality of Life</subject><subject>Questionnaires</subject><subject>Recurrence</subject><subject>Surveys and Questionnaires</subject><subject>United States</subject><subject>Vision Tests</subject><subject>Visual Acuity - physiology</subject><subject>Visual Fields - physiology</subject><issn>0002-9394</issn><issn>1879-1891</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkV1rFjEQhYNY7Gv1JygBUfRiNclmN4k3IkVtoeCFH7dhNjvBlN3sa5KV9t-b9wMLvfFimBl4zjCcQ8gzzt5yxvt33xhjojGtka9Z-4Yx3Yumf0A2XCvTcG34Q7L5h5ySxzlf17VXUj0ip1yqOku1IeFnyCtM1K_RlbBEOi8JafkFkXJGbxFSpuALJrpsS3A04ppCCfk9xZstpoDRIV18VeA9gpaEUGaMpU4BpifkxMOU8emxn5Efnz99P79orr5-uTz_eNU42YnSSMY1DKCQDb2ElkstRuGUhM4AAgjTjh0fBDrvBqW1FrxrjfMdF46PHlh7Rl4d7m7T8nvFXOwcssNpgojLmq1mTBmmeAVf3AOvlzXF-pvlvZS6ljSV6g6US0vOCb3dpjBDurWc2V0Sdp-E3dlsWWv3Sdi-6p4fr6_DjOOd6mh9BV4eAcgOJp8gupDvuE5L0_U77sOBw2ran4DJZre3fQwJXbHjEv7zyl-TcaVo</recordid><startdate>2004</startdate><enddate>2004</enddate><creator>Beck, Roy W</creator><creator>Gal, Robin L</creator><creator>Bhatti, M Tariq</creator><creator>Brodsky, Michael C</creator><creator>Buckley, Edward G</creator><creator>Chrousos, Georgia A</creator><creator>Corbett, James</creator><creator>Eggenberger, Eric</creator><creator>Goodwin, James A</creator><creator>Katz, Barrett</creator><creator>Kaufman, David I</creator><creator>Keltner, John L</creator><creator>Kupersmith, Mark J</creator><creator>Miller, Neil R</creator><creator>Moke, Pamela S</creator><creator>Nazarian, Sarkis</creator><creator>Orengo-Nania, Silvia</creator><creator>Savino, Peter J</creator><creator>Shults, William T</creator><creator>Smith, Craig H</creator><creator>Trobe, Jonathan D</creator><creator>Wall, Michael</creator><creator>Xing, Dongyuan</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>2004</creationdate><title>Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial</title><author>Beck, Roy W ; Gal, Robin L ; Bhatti, M Tariq ; Brodsky, Michael C ; Buckley, Edward G ; Chrousos, Georgia A ; Corbett, James ; Eggenberger, Eric ; Goodwin, James A ; Katz, Barrett ; Kaufman, David I ; Keltner, John L ; Kupersmith, Mark J ; Miller, Neil R ; Moke, Pamela S ; Nazarian, Sarkis ; Orengo-Nania, Silvia ; Savino, Peter J ; Shults, William T ; Smith, Craig H ; Trobe, Jonathan D ; Wall, Michael ; Xing, Dongyuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c452t-4018aba7e0b64a31482d2c74a59aeaa293d51b2ecfcb788821539cf512c1dfa03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Contrast Sensitivity - physiology</topic><topic>Diabetic retinopathy</topic><topic>Diseases of visual field, optic nerve, optic chiasma and optic tracts</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Glucocorticoids - therapeutic use</topic><topic>Health Status Indicators</topic><topic>Humans</topic><topic>Independent sample</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Multiple sclerosis</topic><topic>Multiple Sclerosis - physiopathology</topic><topic>National Institutes of Health (U.S.) - standards</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Ophthalmology</topic><topic>Optic Neuritis - drug therapy</topic><topic>Optic Neuritis - physiopathology</topic><topic>Patients</topic><topic>Quality of Life</topic><topic>Questionnaires</topic><topic>Recurrence</topic><topic>Surveys and Questionnaires</topic><topic>United States</topic><topic>Vision Tests</topic><topic>Visual Acuity - physiology</topic><topic>Visual Fields - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Beck, Roy W</creatorcontrib><creatorcontrib>Gal, Robin L</creatorcontrib><creatorcontrib>Bhatti, M Tariq</creatorcontrib><creatorcontrib>Brodsky, Michael C</creatorcontrib><creatorcontrib>Buckley, Edward G</creatorcontrib><creatorcontrib>Chrousos, Georgia A</creatorcontrib><creatorcontrib>Corbett, James</creatorcontrib><creatorcontrib>Eggenberger, Eric</creatorcontrib><creatorcontrib>Goodwin, James A</creatorcontrib><creatorcontrib>Katz, Barrett</creatorcontrib><creatorcontrib>Kaufman, David I</creatorcontrib><creatorcontrib>Keltner, John L</creatorcontrib><creatorcontrib>Kupersmith, Mark J</creatorcontrib><creatorcontrib>Miller, Neil R</creatorcontrib><creatorcontrib>Moke, Pamela S</creatorcontrib><creatorcontrib>Nazarian, Sarkis</creatorcontrib><creatorcontrib>Orengo-Nania, Silvia</creatorcontrib><creatorcontrib>Savino, Peter J</creatorcontrib><creatorcontrib>Shults, William T</creatorcontrib><creatorcontrib>Smith, Craig H</creatorcontrib><creatorcontrib>Trobe, Jonathan D</creatorcontrib><creatorcontrib>Wall, Michael</creatorcontrib><creatorcontrib>Xing, Dongyuan</creatorcontrib><creatorcontrib>THE OPTIC NEURITIS STUDY GROUP</creatorcontrib><creatorcontrib>Optic Neuritis Study Group</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Beck, Roy W</au><au>Gal, Robin L</au><au>Bhatti, M Tariq</au><au>Brodsky, Michael C</au><au>Buckley, Edward G</au><au>Chrousos, Georgia A</au><au>Corbett, James</au><au>Eggenberger, Eric</au><au>Goodwin, James A</au><au>Katz, Barrett</au><au>Kaufman, David I</au><au>Keltner, John L</au><au>Kupersmith, Mark J</au><au>Miller, Neil R</au><au>Moke, Pamela S</au><au>Nazarian, Sarkis</au><au>Orengo-Nania, Silvia</au><au>Savino, Peter J</au><au>Shults, William T</au><au>Smith, Craig H</au><au>Trobe, Jonathan D</au><au>Wall, Michael</au><au>Xing, Dongyuan</au><aucorp>THE OPTIC NEURITIS STUDY GROUP</aucorp><aucorp>Optic Neuritis Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial</atitle><jtitle>American journal of ophthalmology</jtitle><addtitle>Am J Ophthalmol</addtitle><date>2004</date><risdate>2004</risdate><volume>137</volume><issue>1</issue><spage>77</spage><epage>83</epage><pages>77-83</pages><issn>0002-9394</issn><eissn>1879-1891</eissn><coden>AJOPAA</coden><abstract>To assess visual function more than 10 years after an episode of optic neuritis in patients enrolled in the Optic Neuritis Treatment Trial.
Longitudinal follow-up of a randomized clinical trial.
Vision testing included measures of visual acuity, contrast sensitivity, and visual field. Quality of life was assessed with the National Eye Institute Visual Function Questionnaire.
Examinations were completed on 319 patients. In most patients, visual function test results in the eyes that experienced optic neuritis at study entry (“affected eyes”) were normal or only slightly abnormal after 9.9 to 13.7 years. Visual acuity in the affected eyes was ≥20/20 in 74%, 20/25 to 20/40 in 18%, <20/40 to 20/200 in 5%, and <20/200 in 3%. On average, visual function was worse in patients with multiple sclerosis (MS) than in those without MS. Recurrent optic neuritis in either eye occurred in 35% of patients. Such attacks were more frequent in patients with MS (
P < .001). The National Eye Institute Visual Function Questionnaire scores were lower when visual acuity was abnormal and when MS was present.
Most patients retained good to excellent vision more than 10 years after an attack of optic neuritis. Recurrences were more frequent in patients with MS.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>14700647</pmid><doi>10.1016/S0002-9394(03)00862-6</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-9394 |
| ispartof | American journal of ophthalmology, 2004, Vol.137 (1), p.77-83 |
| issn | 0002-9394 1879-1891 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_80079071 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | Adolescent Adult Biological and medical sciences Contrast Sensitivity - physiology Diabetic retinopathy Diseases of visual field, optic nerve, optic chiasma and optic tracts Female Follow-Up Studies Glucocorticoids - therapeutic use Health Status Indicators Humans Independent sample Male Medical sciences Middle Aged Multiple sclerosis Multiple Sclerosis - physiopathology National Institutes of Health (U.S.) - standards NMR Nuclear magnetic resonance Ophthalmology Optic Neuritis - drug therapy Optic Neuritis - physiopathology Patients Quality of Life Questionnaires Recurrence Surveys and Questionnaires United States Vision Tests Visual Acuity - physiology Visual Fields - physiology |
| title | Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T17%3A35%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Visual%20function%20more%20than%2010%20years%20after%20optic%20neuritis:%20experience%20of%20the%20optic%20neuritis%20treatment%20trial&rft.jtitle=American%20journal%20of%20ophthalmology&rft.au=Beck,%20Roy%20W&rft.aucorp=THE%20OPTIC%20NEURITIS%20STUDY%20GROUP&rft.date=2004&rft.volume=137&rft.issue=1&rft.spage=77&rft.epage=83&rft.pages=77-83&rft.issn=0002-9394&rft.eissn=1879-1891&rft.coden=AJOPAA&rft_id=info:doi/10.1016/S0002-9394(03)00862-6&rft_dat=%3Cproquest_cross%3E3556245451%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1644864449&rft_id=info:pmid/14700647&rft_els_id=S0002939403008626&rfr_iscdi=true |